keyword
https://read.qxmd.com/read/38652826/induction-treatment-for-lupus-nephritis-at-a-high-complexity-hospital-in-chile
#1
JOURNAL ARTICLE
Paulina Ramirez, Andres Giglio, Jorge Verdugo, Francisco Gutierrez
INTRODUCTION: Systemic lupus erythematosus (SLE) causes kidney compromise in up to 40% of patients, contributing significantly to morbidity. Lupus nephritis (LN), an early onset manifestation in most patients, is histologically classified into six types, with types III, IV, and V requiring treatment with induction therapies, usually glucocorticoids with mycophenolate mofetil (MMF) or intravenous cyclophosphamide (IVC). However, up to 60% of patients fail to achieve complete remission, and 27%-66% have subsequent flares...
April 23, 2024: Lupus
https://read.qxmd.com/read/38650934/genetic-causal-relationship-between-immune-diseases-and-migraine-a-mendelian-randomization-study
#2
JOURNAL ARTICLE
Guanglu Li, Shaojie Duan, Tao Zheng, Tiantian Zhu, Baoquan Qu, Lei Liu, Zunjing Liu
BACKGROUND: Migraine has an increased prevalence in several immune disorders, but genetic cause-effect relationships remain unclear. Mendelian randomization (MR) was used in this study to explore whether immune diseases are causally associated with migraine and its subtypes. METHODS: We conducted a two-sample bidirectional multivariate Mendelian randomization study. Single-nucleotide polymorphisms (SNP) for six immune diseases, including rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), type 1 diabetes mellitus (T1D), allergic rhinitis (AR), asthma and psoriasis, were used as genetic instrumental variables...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38648095/mapping-theme-evolution-and-identifying-hotspots-in-biomarkers-of-systemic-lupus-erythematosus-based-on-global-research
#3
JOURNAL ARTICLE
Haitao Yu, Yafei Xie, Meiying Zuo, Jianguo Xu, Lili Jiang, Ting Liu, Renmei Wang, Dexuan Hu, Zhenglei Cha
Objective: To perform a bibliometric analysis in the field of biomarkers for systemic lupus erythematosus. Methods: Publications were from Web of Science. Microsoft Excel, VOSviewer, Science Mapping Analysis software Tool, CiteSpace and Tableau were used for analysis. Results: A total of 1112 publications were identified; 1503 institutions from 69 countries contributed, with the highest outputs from China and Karolinska University Hospital. Petri had a tremendous impact. Academic collaborations were localized...
April 22, 2024: Biomarkers in Medicine
https://read.qxmd.com/read/38647337/targeting-t-bet-expressing-b-cells-for-therapeutic-interventions-in-autoimmunity
#4
JOURNAL ARTICLE
Athanasios Sachinidis, Malamatenia Lamprinou, Theodoros Dimitroulas, Alexandros Garyfallos
Apart from serving as a Th1 lineage commitment regulator, transcription factor T-bet is also expressed in other immune cell types and thus orchestrates their functions. In case of B cells, more specifically, T-bet is responsible for their isotype switching to specific IgG sub-classes (IgG2a/c in mice and IgG1/3 in humans). In various autoimmune disorders, such as systemic lupus erythematosus and/or rheumatoid arthritis, subsets of T-bet expressing B cells, known as age-associated B cells (CD19+CD11c+CD21-T-bet+) and/or double-negative B cells (CD19+IgD-CD27-T-bet+), display an expansion and seem to drive disease pathogenesis...
April 22, 2024: Clinical and Experimental Immunology
https://read.qxmd.com/read/38643729/multi-omics-study-reveals-different-pathogenesis-of-the-generation-of-skin-lesions-in-sle-and-idle-patients
#5
JOURNAL ARTICLE
Qianwen Li, Chen Jia, Wenjing Pan, Hongmei Liu, Congli Tang, Daniel Weber, Kaili Chen, Hai Long, Miranda L Byrne-Steele, Jian Han, Nongyue He, Rong Xiao, Ming Zhao, Nan Che, Qing Guo, Guangji Gui, Shanshan Li, Henan Si, Shuping Guo, Hongye Liu, Gang Wang, Guannan Zhu, Bin Yang, Yu Wang, Yan Ding, Xianxu Yang, Yoshimura Akihiko, Liwei Lu, Christopher Chang, Vera Chan, Chak-Sing Lau, Hai Qi, Wanli Liu, Song Li, Haijing Wu, Qianjin Lu
Lupus erythematosus (LE) is a heterogeneous, antibody-mediated autoimmune disease. Isolate discoid LE (IDLE) and systematic LE (SLE) are traditionally regarded as the two ends of the spectrum, ranging from skin-limited damage to life-threatening multi-organ involvement. Both belong to LE, but IDLE and SLE differ in appearance of skin lesions, autoantibody panels, pathological changes, treatments, and immunopathogenesis. Is discoid lupus truly a form of LE or is it a completely separate entity? This question has not been fully elucidated...
April 20, 2024: Journal of Autoimmunity
https://read.qxmd.com/read/38635961/panoptosis-features-a-humanized-nsg-murine-model-of-sjogren-s-syndrome
#6
JOURNAL ARTICLE
Yiying Yang, Huali Zhang, Xiaoyu Xiao, Muyao Guo
Sjogren's syndrome (SS) is a complex systemic autoimmune disease. This study aims to elucidate a humanized NOD-Prkdcscid Il2rgem1 /Smoc (NSG) murine model to better clarify the pathogenesis of SS. NSG female mice were adoptively transferred with 10 million peripheral blood mononuclear cells (PBMCs) through the tail vein from healthy controls (HCs), primary Sjogren's syndrome (pSS), and systemic lupus erythematosus (SLE) patients on D0. The mice were subcutaneously injected with C57/B6j submandibular gland (SG) protein or phosphate-buffered saline on D3, D17 and D31, respectively...
April 18, 2024: DNA and Cell Biology
https://read.qxmd.com/read/38631847/higher-mortality-risk-from-gynaecological-neoplasms-and-non-hodgkin-s-lymphoma-in-patients-with-systemic-lupus-erythematosus-an-observational-study-from-the-spanish-national-registry
#7
JOURNAL ARTICLE
Víctor Moreno-Torres, María Martínez-Urbistondo, José Vázquez-Comendador, María Mateos Seirul-Lo, Raquel Castejón, Ana Huerta, Pedro Durán-Del Campo, Pablo Tutor, Susana Mellor-Pita
OBJECTIVE: To evaluate the impact of the different types of neoplasms and lineages on mortality of patients with SLE. METHODS: Retrospective and observational comparison of the neoplasm-related deaths in patients with SLE and the general Spanish population reported in the Spanish Hospital Discharge Database. To determine the impact of SLE on the risk of dying from each neoplasm lineage, a binary logistic regression considering age, female sex, tobacco and alcohol consumption, was performed...
April 17, 2024: Lupus Science & Medicine
https://read.qxmd.com/read/38619739/mendelian-causes-of-autoimmunity-the-lupus-phenotype
#8
REVIEW
Maud Tusseau, Samira Khaldi-Plassart, Jade Cognard, Sebastien Viel, Liliane Khoryati, Sarah Benezech, Anne-Laure Mathieu, Fréderic Rieux-Laucat, Brigitte Bader-Meunier, Alexandre Belot
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that is characterized by its large heterogeneity in terms of clinical presentation and severity. The pathophysiology of SLE involves an aberrant autoimmune response against various tissues, an excess of apoptotic bodies, and an overproduction of type-I interferon. The genetic contribution to the disease is supported by studies of monozygotic twins, familial clustering, and genome-wide association studies (GWAS) that have identified numerous risk loci...
April 15, 2024: Journal of Clinical Immunology
https://read.qxmd.com/read/38616341/predictors-of-damage-accrual-and-its-impact-on-health-related-quality-of-life-of-thrombotic-antiphospholipid-syndrome-independent-validation-of-the-damage-index-for-antiphospholipid-syndrome-diaps
#9
JOURNAL ARTICLE
Pedro Gaspar, Ana Sofia M Fernandes, Ana Mafalda Abrantes, Inês Parreira, Inês Silva, Ryan C Silva, Mariana B Nobre, Joana R Martins, Catarina Mota
OBJECTIVES: We aim to independently assess the validity of the damage index for antiphospholipid syndrome (DIAPS) in thrombotic antiphospholipid syndrome (APS) patients by exploring the prevalence and risk factors of organ damage and evaluating its impact on health-related quality of life (HR-QoL). METHODS: Cross-sectional study including all thrombotic APS patients (Sydney criteria) attending a Portuguese tertiary centre. Damage was assessed using the DIAPS, and HR-QoL using the 3- and 5-level EuroQol HR-QoL (EQ-D5-3L and 5L), and Visual Analogue Scale (VAS) applied via a phone questionnaire...
April 14, 2024: Lupus
https://read.qxmd.com/read/38610754/biomarkers-in-systemic-lupus-erythematosus-along-with-metabolic-syndrome
#10
REVIEW
Fernanda Isadora Corona-Meraz, Mónica Vázquez-Del Mercado, Flavio Sandoval-García, Jesus-Aureliano Robles-De Anda, Alvaro-Jovanny Tovar-Cuevas, Roberto-Carlos Rosales-Gómez, Milton-Omar Guzmán-Ornelas, Daniel González-Inostroz, Miguel Peña-Nava, Beatriz-Teresita Martín-Márquez
Metabolic syndrome (MetS) is a group of physiological abnormalities characterized by obesity, insulin resistance (IR), and hypertriglyceridemia, which carry the risk of developing cardiovascular disease (CVD) and type 2 diabetes (T2D). Immune and metabolic alterations have been observed in MetS and are associated with autoimmune development. Systemic lupus erythematosus (SLE) is an autoimmune disease caused by a complex interaction of environmental, hormonal, and genetic factors and hyperactivation of immune cells...
March 29, 2024: Journal of Clinical Medicine
https://read.qxmd.com/read/38609158/disentangling-the-riddle-of-systemic-lupus-erythematosus-with-antiphospholipid-syndrome-blood-transcriptome-analysis-reveals-a-less-pronounced-ifn-signature-and-distinct-molecular-profiles-in-venous-versus-arterial-events
#11
JOURNAL ARTICLE
Dionysis Nikolopoulos, Catherine Loukogiannaki, George Sentis, Panagiotis Garantziotis, Theodora Manolakou, Noemin Kapsala, Myrto Nikoloudaki, Antigone Pieta, Sofia Flouda, Ioannis Parodis, George Bertsias, Antonis Fanouriakis, Anastasia Filia, Dimitrios T Boumpas
INTRODUCTION: Systemic lupus erythematosus with antiphospholipid syndrome (SLE-APS) represents a challenging SLE endotype whose molecular basis remains unknown. METHODS: We analysed whole-blood RNA-sequencing data from 299 patients with SLE (108 SLE-antiphospholipid antibodies (aPL)-positive, including 67 SLE-APS; 191 SLE-aPL-negative) and 72 matched healthy controls (HC). Pathway enrichment analysis, unsupervised weighted gene coexpression network analysis and machine learning were applied to distinguish disease endotypes...
April 12, 2024: Annals of the Rheumatic Diseases
https://read.qxmd.com/read/38605949/enhanced-gata4-expression-in-senescent-systemic-lupus-erythematosus-monocytes-promotes-high-levels-of-ifn%C3%AE-production
#12
JOURNAL ARTICLE
Taiga Kuga, Asako Chiba, Goh Murayama, Kosuke Hosomi, Tomoya Nakagawa, Yoshiyuki Yahagi, Daisuke Noto, Makio Kusaoi, Fuminori Kawano, Ken Yamaji, Naoto Tamura, Sachiko Miyake
Enhanced interferon α (IFNα) production has been implicated in the pathogenesis of systemic lupus erythematosus (SLE). We previously reported IFNα production by monocytes upon activation of the stimulator of IFN genes (STING) pathway was enhanced in patients with SLE. We investigated the mechanism of enhanced IFNα production in SLE monocytes. Monocytes enriched from the peripheral blood of SLE patients and healthy controls (HC) were stimulated with 2'3'-cyclic GAMP (2'3'-cGAMP), a ligand of STING...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38605883/the-aconitate-decarboxylase-1-itaconate-pathway-modulates-immune-dysregulation-and-associates-with-cardiovascular-disease-markers-in-sle
#13
Eduardo Patiño-Martinez, Shuichiro Nakabo, Kan Jiang, Carmelo Carmona-Rivera, Wanxia Li Tsai, Dillon Claybaugh, Zu-Xi Yu, Aracely Romero, Eric Bohrnsen, Benjamin Schwarz, Miguel A Solís-Barbosa, Luz P Blanco, Mohammad Naqi, Yenealem Temesgen-Oyelakim, Michael Davis, Zerai Manna, Nehal Mehta, Faiza Naz, Stephen Brooks, Stefania dell'Orso, Sarfaraz Hasni, Mariana J Kaplan
OBJECTIVE: The Krebs cycle enzyme Aconitate Decarboxylase 1 (ACOD1) mediates itaconate synthesis in myeloid cells.. Previously, we reported that administration of 4-octyl itaconate abrogated lupus phenotype in mice. Here, we explore the role of the endogenous ACOD1/itaconate pathway in the development of murine lupus as well as their relevance in premature cardiovascular damage in SLE. METHODS: We characterized Acod1 protein expression in bone marrow-derived macrophages and human monocyte-derived macrophages, following a TLR7 agonist (imiquimod, IMQ)...
February 22, 2024: medRxiv
https://read.qxmd.com/read/38604461/antiphospholipid-syndrome-in-the-era-of-covid-19-two-sides-of-a-coin
#14
REVIEW
Naim Mahroum, Mona Habra, Mohamad Aosama Alrifaai, Yehuda Shoenfeld
In addition to the respiratory symptoms associated with COVID-19, the disease has consistently been linked to many autoimmune diseases such as systemic lupus erythematous and antiphospholipid syndrome (APS). APS in particular was of paramount significance due to its devastating clinical sequela. In fact, the hypercoagulable state seen in patients with acute COVID-19 and the critical role of anticoagulant treatment in affected individuals shed light on the possible relatedness between APS and COVID-19. Moreover, the role of autoimmunity in the assumed association is not less important especially with the accumulated data available regarding the autoimmunity-triggering effect of SARS-CoV-2 infection...
April 9, 2024: Autoimmunity Reviews
https://read.qxmd.com/read/38599668/novel-potential-lncrna-biomarker-in-b-cells-indicates-essential-pathogenic-pathway-activation-in-patients-with-sle
#15
JOURNAL ARTICLE
Xinyi Zhu, Yashuo Chen, Zhihua Yin, Yutong Zhang, Yiwei Shen, Dai Dai, Xiaojing Lin, Ling-Hua Zou, Nan Shen, Zhizhong Ye, Huihua Ding, Guojun Hou
OBJECTIVES: Systemic lupus erythematosus (SLE) is a highly heterogeneous disease, and B cell abnormalities play a central role in the pathogenesis of SLE. Long non-coding RNAs (lncRNAs) have also been implicated in the pathogenesis of SLE. The expression of lncRNAs is finely regulated and cell-type dependent, so we aimed to identify B cell-expressing lncRNAs as biomarkers for SLE, and to explore their ability to reflect the status of SLE critical pathway and disease activity. METHODS: Weighted gene coexpression network analysis (WGCNA) was used to cluster B cell-expressing genes of patients with SLE into different gene modules and relate them to clinical features...
April 10, 2024: Lupus Science & Medicine
https://read.qxmd.com/read/38597902/efficacy-of-anifrolumab-in-long-term-intractable-alopecia-due-to-discoid-lupus-erythematosus
#16
JOURNAL ARTICLE
Naoto Azuma, Masaru Natsuaki, Naoaki Hashimoto, Takeo Abe, Suzu Ueda, Yuko Ohno, Masatoshi Jinnin, Kiyoshi Matsui
Alopecia associated with lupus erythematosus is broadly classified into reversible nonscarring alopecia seen in the acute phase, such as worsening of systemic lupus erythematosus (SLE) and cicatricial alopecia seen in chronic cutaneous lupus erythematosus represented by discoid lupus erythematosus (DLE). In DLE-induced alopecia, early therapeutic intervention before developing scarring alopecia is important, but the condition is often resistant to conventional treatment. Anifrolumab (ANI), a novel therapeutic agent for SLE that inhibits type I interferon activity, has been shown to be effective against acute skin lesions, including alopecia, in patients with SLE...
April 10, 2024: Modern rheumatology case reports
https://read.qxmd.com/read/38596672/unraveling-ifn-i-response-dynamics-and-tnf-crosstalk-in-the-pathophysiology-of-systemic-lupus-erythematosus
#17
JOURNAL ARTICLE
Laura C Van Eyndhoven, Eleni Chouri, Catarina I Matos, Aridaman Pandit, Timothy R D J Radstake, Jasper C A Broen, Abhyudai Singh, Jurjen Tel
INTRODUCTION: The innate immune system serves the crucial first line of defense against a wide variety of potential threats, during which the production of pro-inflammatory cytokines IFN-I and TNFα are key. This astonishing power to fight invaders, however, comes at the cost of risking IFN-I-related pathologies, such as observed during autoimmune diseases, during which IFN-I and TNFα response dynamics are dysregulated. Therefore, these response dynamics must be tightly regulated, and precisely matched with the potential threat...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38595261/-vertebral-fractures-combined-with-prolonged-activated-partial-prothrombin-time-a-case-report
#18
JOURNAL ARTICLE
Xinzhu Bai, Jinhui He, Songsong Lu, Chun Li, Yilin Wang, Jian Xiong
With the development of modern medical standards, autoimmune diseases and their associated successive osteoporosis have received increasing attention in recent years. Patients with autoimmune diseases, due to the characteristics of the disease and the prolonged use of glucocorticoid hormone therapy, may affect the bone formation and bone absorption of the patient, followed by severe successive osteoporosis, thereby increasing the risk of osteoporotic vertebral fractures. Vertebral compression fractures of the spine are common fracture types in patients with osteoporotic fractures...
April 18, 2024: Beijing da Xue Xue Bao. Yi Xue Ban, Journal of Peking University. Health Sciences
https://read.qxmd.com/read/38594808/considering-belimumab-during-pregnancy-a-more-viable-option-over-time
#19
JOURNAL ARTICLE
Paloma Vela-Casasempere, Rocío Caño Alameda, Silvia Gómez Sabater, Silvia Cortell Aznar, Encarnación Pérez Pascual
OBJECTIVE: To share our experience with belimumab in lupus pregnant women and to review the relevant published literature on its use in this scenario. METHODS: A prospective observational study of pregnant patients with lupus was conducted. Additionally, MEDLINE and EMBASE databases were searched, and a secondary hand search of the literature was performed. Studies were evaluated and visualised descriptively. RESULTS: Sixteen pregnancies of 12 lupus women were included, six (involving eight pregnancies) received belimumab throughout their illness, five of them during some period of gestation...
April 9, 2024: Lupus
https://read.qxmd.com/read/38593970/fecal-microbiota-transplantation-in-autoimmune-diseases-an-extensive-paper-on-a-pathogenetic-therapy
#20
REVIEW
Isa Seida, Maisam Al Shawaf, Naim Mahroum
The role of infections in the pathogenesis of autoimmune diseases has long been recognized and reported. In addition to infectious agents, the internal composition of the "friendly" living bacteria, (microbiome) and its correlation to immune balance and dysregulation have drawn the attention of researchers for decades. Nevertheless, only recently, scientific papers regarding the potential role of transferring microbiome from healthy donor subjects to patients with autoimmune diseases has been proposed. Fecal microbiota transplantation or FMT, carries the logic of transferring microorganisms responsible for immune balance from healthy donors to individuals with immune dysregulation or more accurately for our paper, autoimmune diseases...
April 7, 2024: Autoimmunity Reviews
keyword
keyword
116540
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.